A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (NCT03675308)

🧪 Interventions in This Study

• Placebo (BIOLOGICAL)
• Risankizumab (BIOLOGICAL)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (256 Sites)

Showing the first 25 of 256 sites.

• Pinnacle Research Group /ID# 167955 — Anniston, Alabama
• Sun Valley Arthritis Center Ltd. /ID# 200270 — Peoria, Arizona
• AZ Arthritis and Rheumotology Research, PLLC /ID# 209873 — Phoenix, Arizona
• Arizona Arthritis & Rheumatology Research, PLLC /ID# 209875 — Tucson, Arizona
• Southern Arizona VA Health Care System /ID# 209247 — Tucson, Arizona
• Arthritis and Rheumatism Associates /ID# 209882 — Jonesboro, Arkansas
• Valerius Medical Group & Research Center /ID# 207428 — Los Alamitos, California
• Rheumatology Center of San Diego /ID# 201642 — San Diego, California
• Inland Rheum Clin Trials Inc. /ID# 201641 — Upland, California
• Medvin Clinical Research /ID# 211127 — Whittier, California
• New England Research Associates, LLC /ID# 207237 — Bridgeport, Connecticut
• Danbury Clinical Research, LLC /ID# 209517 — Danbury, Connecticut
• Arthritis & Osteoporosis Center /ID# 207236 — Hamden, Connecticut
• Arthritis & Rheumatic Disease Specialties /ID# 210802 — Aventura, Florida
• Rheumatology Associates of South Florida (RASF) - Clinical Research /ID# 211099 — Boca Raton, Florida
• SIMED Health, LLC /ID# 207461 — Gainesville, Florida
• Sweet Hope Research Specialty Inc /ID# 209393 — Hialeah, Florida
• Jacksonville Center for Clinical Research /ID# 209876 — Jacksonville, Florida
• Rheum Assoc of Central FL /ID# 201622 — Orlando, Florida
• HMD Research LLC /ID# 208427 — Orlando, Florida
• IRIS Research and Development, LLC /ID# 208955 — Plantation, Florida
• ForCare Clinical Research /ID# 168034 — Tampa, Florida
• Arthritis and Rheumatology /ID# 168046 — Atlanta, Georgia
• Affinity Clinical Research /ID# 210816 — Oak Brook, Illinois
• OrthoIllinois /ID# 205300 — Rockford, Illinois

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Psoriatic Arthritis

• A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs — Gilbert, Arizona
• Psoriatic Arthritis D2P Screening — Philadelphia, Pennsylvania
• Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis — Dothan, Alabama
• Apremilast Pregnancy Exposure Registry — La Jolla, California
• Psorcast Mobile Study — Seattle, Washington

Explore by condition: All Psoriatic Arthritis clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.